Research Article
Infliximab Trough Levels and Quality of Life in Patients with Inflammatory Bowel Disease in Maintenance Therapy
Table 1
Patients’ main characteristics according to infliximab levels.
| Characteristics | | | value | n | % | n | % |
| Age | | | | | | ≤40 years | 29 | 61.7 | 18 | 38.3 | 0.803 | >40 years | 14 | 58.3 | 10 | 41.7 | | Gender | | | | | | Male | 23 | 53.5 | 20 | 46.5 | 0.146 | Female | 20 | 71.4 | 8 | 28.6 | | Ethnicity | | | | | | White | 36 | 57.1 | 27 | 42.9 | 0.135 | Non-white | 7 | 87.5 | 1 | 12.5 | | Education | | | | | | Low | 11 | 57.9 | 8 | 42.1 | 0.790 | High | 32 | 61.5 | 20 | 38.5 | | Occupation | | | | | | Unemployed | 17 | 73.9 | 6 | 26.1 | 0.128 | Employed | 26 | 54.2 | 22 | 45.8 | | Condition | | | | | | Crohn’s disease | 35 | 64.8 | 19 | 35.2 | 0.257 | Ulcerative colitis | 8 | 47.1 | 9 | 52.9 | | IFX duration | | | | | | ≤2 years | 20 | 57.1 | 15 | 42.9 | 0.631 | >2 years | 23 | 63.9 | 13 | 36.1 | | Azathioprine | | | | | | No | 26 | 57.8 | 19 | 42.2 | 0.618 | Yes | 17 | 65.4 | 9 | 34.6 | | Smoking | | | | | | No | 41 | 59.4 | 28 | 40.6 | 0.515 | Yes | 2 | 100 | 0 | 0 | |
|
|